Background: The epidemic of diabetes mellitus is one of the leading causes of mortality globally. Therefore, the goal of the registry is to create a database on individuals with diabetes mellitus that may be utilized to provide data on clinico epidemiological profile of Diabetes Mellitus in the real world. Methods: Data for this registry is captured at seven sites across India recognized by Biotechnology Industry Research Assistance Council (BIRAC). This is an observational multi-centric study, which registered around 25077 Diabetic patients over a period of 3 years (December 2023. Results: Out of 25077 patients, 12793 (51%) were male and 12284 (49%) females. There were 11443(46%) rural patients, and 13575(54%) urban patients. Most patients registered were over 50 years. Diabetes was seen as a burden for 46% of individuals and their families. Less than 40% of patients exercised. Over half of the patients had a family history of diabetes. This explains the exponential rise of diabetes mellitus over generations and the significance of preventing it. Conclusion: This registry revealed the impact of the clinic epidemiological aspects of Diabetes Mellitus on a larger number of samples. Future healthcare planners, researchers, and government officials will benefit from this diabetes registry in developing primary and secondary preventive initiatives that might minimize the rising healthcare burden of diabetes.

The authors have declared no competing interest.

https://www.medrxiv.org/content/10.1101/2024.08.22.24311654v1

This study was funded by Biotechnology Industry Research Assistance Council (BIRAC)

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Committee of M S Ramaiah Medical College and Hospitals gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors